These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 6501568
1. Role of thrombospondin in platelet aggregation. Leung LL. J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568 [Abstract] [Full Text] [Related]
5. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Boukerche H, McGregor JL. Eur J Biochem; 1988 Jan 15; 171(1-2):383-92. PubMed ID: 3338471 [Abstract] [Full Text] [Related]
6. Immunocytochemical study of the binding of fibrinogen and thrombospondin to ADP- and thrombin-stimulated human platelets. Hourdillé P, Hasitz M, Belloc F, Nurden AT. Blood; 1985 Apr 15; 65(4):912-20. PubMed ID: 2579690 [Abstract] [Full Text] [Related]
8. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM. J Clin Invest; 1986 Apr 15; 77(4):1272-7. PubMed ID: 3007578 [Abstract] [Full Text] [Related]
9. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins. Heilmann E, Hourdillé P, Pruvost A, Paponneau A, Nurden AT. Arterioscler Thromb; 1991 Apr 15; 11(3):704-18. PubMed ID: 2029507 [Abstract] [Full Text] [Related]
10. Characterization of the platelet agglutinating activity of thrombospondin. Haverstick DM, Dixit VM, Grant GA, Frazier WA, Santoro SA. Biochemistry; 1985 Jun 18; 24(13):3128-34. PubMed ID: 4027236 [Abstract] [Full Text] [Related]
13. Expression of intracellular fibrinogen on the surface of stimulated platelets. Courtois G, Ryckewaert JJ, Woods VL, Ginsberg MH, Plow EF, Marguerie GA. Eur J Biochem; 1986 Aug 15; 159(1):61-7. PubMed ID: 3743572 [Abstract] [Full Text] [Related]
14. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin. Legrand C, Morandi V, Mendelovitz S, Shaked H, Hartman JR, Panet A. Arterioscler Thromb; 1994 Nov 15; 14(11):1784-91. PubMed ID: 7947604 [Abstract] [Full Text] [Related]
15. Recognition of platelet-associated fibrinogen by polyclonal antibodies: correlation with platelet aggregation. Peerschke EI. Blood; 1992 Apr 15; 79(8):2028-33. PubMed ID: 1562729 [Abstract] [Full Text] [Related]
16. Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein IIb-IIIa complex. Asch AS, Leung LL, Polley MJ, Nachman RL. Blood; 1985 Oct 15; 66(4):926-34. PubMed ID: 2994782 [Abstract] [Full Text] [Related]
17. Interaction of platelet factor 4 with human platelets. Capitanio AM, Niewiarowski S, Rucinski B, Tuszynski GP, Cierniewski CS, Hershock D, Kornecki E. Biochim Biophys Acta; 1985 Apr 17; 839(2):161-73. PubMed ID: 4039192 [Abstract] [Full Text] [Related]
18. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Legrand C, Dubernard V, Nurden AT. Blood; 1989 Apr 17; 73(5):1226-34. PubMed ID: 2539213 [Abstract] [Full Text] [Related]
19. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, Martinez J, Murphy S. J Lab Clin Med; 1986 Sep 17; 108(3):246-52. PubMed ID: 3018111 [Abstract] [Full Text] [Related]
20. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients. Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham MA, Mustard JF. Blood; 1987 Jul 17; 70(1):221-6. PubMed ID: 3109523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]